TRPM8 and osteosarcoma: Treatment of several osteosarcoma cell lines (143B, U2OS, HOS, and MG-63), with AMTB, a TRPM8 antagonist, results in suppressed proliferation and metastasis, and induces cellular apoptosis (207).